JPRN-UMIN000009055已完成2 期
ow-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1) - Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
iigata University, Dept of Radiology, Japanese Radiation Oncology Study Group0 个研究点目标入组 70 人开始时间: 2012年10月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) severe decline in neurocognitive function or language ability at baseline 2) history of brain radiation therapy 3) history of brain surgery of brain metastases 4) small cell carcinoma, germinoma, lymphoma 5) any other reasons not to fit to this study
研究者
相似试验
已完成
3 期
Whole Brain Radiotherapy following local treatment of melanoma brain metastasesMelanoma brain metastasesCancer - Malignant melanomaACTRN12607000512426Melanoma and Skin Cancer (MASC) Trials215
尚未招募
不适用
Simultaneous Integrated Boost Radiation Therapy with concomitant Capecitabine and Mitomycin-C chemotherapy for locally advanced Anal CarcinomaAnal carcinomacancer of the anus1000211210017991NL-OMON31876Antoni van Leeuwenhoek Ziekenhuis20
招募中
2 期
Role of Copper in addition to whole brain radiotherapy in brain metastases in lung canceCTRI/2020/09/027794Jai Prakash Agarwal
已完成
2 期
Phase 2 study of whole brain radiotherapy with hippocampal-avoidance and simultaneous integrated boost to brain metastases using intensity modulated radiotherapyBrain metastasisJPRN-UMIN000010226Division of Radiation Oncology and division of Neurooncology, National Cancer Center Hospital, Tokyo, Japan54
已完成
2 期
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imagingC71Malignant neoplasm of brainDRKS00004598niversitätsklinikum Freiburg136